Medtronic announced the start of the SPYRAL AFFIRM study, which is evaluating the long-term safety, efficacy, and durability of renal denervation with Medtronic’s Symplicity system in “real-world” patients with uncontrolled hypertension.
Cardiovascular Catch-Up: Medtronic And Edwards Make Headlines At TCT Conference
The first half of November was full of cardiovascular device news, led by clinical trial results from renal denervation and transcatheter aortic valve trials presented at the Transcatheter Cardiovascular Therapeutics (TCT) conference.
